Noninvasive urine exfoliated cell fluorescent staining method
Through non-invasive urine shedding cell fluorescence staining method, combined with acridine orange staining fluorescence microscopy technology, the invasive and hyposensitivity problems in bladder cancer diagnosis are solved, and early, high-sensitivity and high-specific bladder cancer detection is achieved. A fast, accurate and economical screening method.
Patent Information
- Application Number
- CN202411057714.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-02
- Publication Date
- 2024-11-26
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing bladder cancer diagnosis methods have problems of invasiveness, pain, hyposensitivity and insufficient specificity, especially in early screening and recurrence testing.
Using non-invasive urine shedding cell fluorescence staining method, using acridine orange staining fluorescence microscopy technology, the early stage of bladder cancer is improved by optimizing sample collection, cell concentration, smear production, staining and microscopy examination processes, combining cell morphology and chemical characteristics. Detection rate.
It significantly improves the detection sensitivity and specificity of bladder cancer, reduces the missed detection rate, and provides a fast, accurate and cost-effective screening method that can identify malignant cells early and reduces the risk of misdiagnosis.
